fbpx
Menu

ReShape Lifesciences Announces Third Quarter 2018 Financial Results

Share

Recent Highlights and Accomplishments


– Reported revenues of $350 thousand in the third quarter of 2018

– Achieved target cash burn goal of $1.8 million per month during the third quarter of 2018

[Read on via official release]

Source: US SEC
View full document:
8-K_for_ReShape_Lifesciences_Inc_8-K-11-14-2018